Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

JAGX

Jaguar Health, Inc.

Healthcare · Pharmaceutical Preparations

$6.02Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Jaguar Health, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -59% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -59% YoY in Q2 FY2026

Pipeline evidence · 0d ago

JAGX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on JAGX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full JAGX earnings analysis

Reported figures for Jaguar Health, Inc. — research only, not investment advice.

Revenue YoY
-58.7%

Latest Intelligence

Updated

What happened recently for Jaguar Health, Inc. (JAGX) — events, not interpretation.

Event
Reported Q2 2026 revenue -59% YoY.
Also
Last session September 28, 2026 at $6.02.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Jaguar Health, Inc. (JAGX)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Jaguar Health, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.03B
Revenue:
$3.24M

JAGX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Jaguar Health, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.